Company / Operating Cash Flow
Glaukos Corp. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$14.8M
FY2025
5-year range
-$61.3M / $24.7M
FY2021-FY2025
Trend
+75.9%
vs FY2024
Sector context
#138 of 158
Health Care
What the data says
Glaukos Corp.'s operating cash flow of -$15M is lower than 87% of companies in the Health Care sector (FY2025). Operating Cash Flow returned to growth in FY2025 after 3 years of decline, reaching -$15M.
Based on SEC 10-K filings.
-$15M in FY2025.
Improved from -$58M to -$15M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 158This company -$14.8M Sector average $1.0B
▼
-101.4% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow increased 75.9% year-over-year.
- Ranks #138 out of 158 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2017.
- Lowest operating cash flow in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$14.8M | +75.9% |
| FY2024 | -$61.3M | -6.2% |
| FY2023 | -$57.8M | -74.6% |
| FY2022 | -$33.1M | -233.9% |
| FY2021 | $24.7M | +207.5% |
| FY2020 | -$23.0M | -6129.8% |
| FY2019 | -$369.0K | -102.0% |
| FY2018 | $18.9M | -27.7% |
| FY2017 | $26.1M | +112.0% |
| FY2016 | $12.3M | +662.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026